Rapid construction of Adeno-associated virus vectors expressing multiple short hairpin RNAs with high antiviral activity against echovirus 30

Oligonucleotides

Volumn 20, Issue 4, 2010, Pages 191-198

  Rothe, Diana ^a,b   Wajant, Gisela ^a   Grunert, Hans Peter ^c   Zeichhardt, Heinz ^c   Fechner, Henry ^b,c   Kurreck, Jens ^a,b  

^a UNIVERSITY OF STUTTGART   (Germany)

^b TECHNISCHE UNIVERSITÄT BERLIN   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; SHORT HAIRPIN RNA;

ANTIVIRAL ACTIVITY; ARTICLE; DOWN REGULATION; ECHO VIRUS; GENE DELETION; GENE EXPRESSION; GENE INSERTION; GENE SILENCING; HUMAN; HUMAN CELL; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; VIRUS REPLICATION;

ANTIGENS, CD55; BASE SEQUENCE; CELL LINE, TUMOR; DEPENDOVIRUS; ECHOVIRUS INFECTIONS; ENTEROVIRUS B, HUMAN; GENETIC VECTORS; HEK293 CELLS; HELA CELLS; HUMANS; RNA INTERFERENCE; RNA, SMALL INTERFERING; RNA, VIRAL; TRANSFECTION; VIRUS REPLICATION;

ADENO-ASSOCIATED VIRUS; HUMAN ECHOVIRUS 30;

EID: 77955678060     PISSN: 15454576     EISSN: None     Source Type: Journal    
DOI: 10.1089/oli.2010.0236     Document Type: Article

References (35)

1. AHN, J., JUN, E.S., LEE, H.S., YOON, S.Y., KIM, D., JOO, C.H., KIM, Y.K., and LEE, H. (2005). A small interfering RNA targeting coxsackievirus B3 protects permissive HeLa cells from viral challenge. J. Virol. 79, 8620-8624.
2. ANDERSON, J., and AKKINA, R. (2007). Complete knockdown of CCR5 by lentiviral vector-expressed siRNAs and protection of transgenic macrophages against HIV-1 infection. Gene Ther. 14, 1287-1297.
3. BERKHOUT, B. (2009). Toward a durable anti-HIV gene therapy based on RNA interference. Ann. N. Y. Acad. Sci. 1175, 3-14.
4. BODEN, D., PUSCH, O., LEE, F., TUCKER, L., and RAMRAT-NAM, B. (2003). Human immunodeficiency virus type 1 escape from RNA interference. J. Virol. 77, 11531-11535.
5. CDC. (2006). Enterovirus surveillance\United States, 2002-2004. MMWR. Morb. Mortal. Wkly. Rep. 55, 153-156.
6. DAS, A.T., BRUMMELKAMP, T.R., WESTERHOUT, E.M., VINK, M., MADIREDJO, M., BERNARDS, R., and BERKHOUT, B. (2004). Human immunodeficiency virus type 1 escapes from RNA interference-mediated inhibition. J. Virol. 78, 2601-2605.
7. DAYA, S., and BERNS, K.I. (2008). Gene therapy using adeno-associated virus vectors. Clin. Microbiol. Rev. 21, 583-593.
8. FECHNER, H., PINKERT, S., WANG, X., SIPO, I., SUCKAU, L., KURRECK, J., DORNER, A., SOLLERBRANT, K., ZEICH-HARDT, H., GRUNERT, H.P., et al. (2007). Coxsackievirus B3 and adenovirus infections of cardiac cells are efficiently inhibited by vector-mediated RNA interference targeting their common receptor. Gene Ther. 14, 960-971.
9. FECHNER, H., SIPO, I., WESTERMANN, D., PINKERT, S., WANG, X., SUCKAU, L., KURRECK, J., ZEICHHARDT, H., MULLER, O., VETTER, R., et al. (2008). Cardiac-targeted RNA interference mediated by an AAV9 vector improves cardiac function in coxsackievirus B3 cardiomyopathy. J. Mol. Med. 86, 987-997.
10. GRIMM, D. (2002). Production methods for gene transfer vectors based on adeno-associated virus serotypes. Methods 28, 146-157.
11. GRIMM, D., and KAY, M.A. (2007). RNAi and gene therapy: a mutual attraction. Hematol. Am. Soc. Hematol. Educ. Program 473-481.
12. JI, J., WERNLI, M., KLIMKAIT, T., and ERB, P. (2003). Enhanced gene silencing by the application of multiple specific small interfering RNAs. FEBS Lett. 552, 247-252.
13. JINEK, M., and DOUDNA, J.A. (2009). A three-dimensional view of the molecular machinery of RNA interference. Nature 457, 405-412.
14. JOHNSTON, S.L., and SIEGEL, C.S. (1990). Presumptive identification of enteroviruses with RD, HEp-2, and RMK cell lines. J. Clin. Microbiol. 28, 1049-1050.
15. KOLLER, E., PROPP, S., MURRAY, H., LIMA, W., BHAT, B., PRAKASH, T.P., ALLERSON, C.R., SWAYZE, E.E., MAR-CUSSON, E.G., and DEAN, N.M. (2006). Competition for RISC binding predicts in vitro potency of siRNA. Nucleic Acids Res. 34, 4467-4476.
16. KURRECK, J. (2009). RNA interference: from basic research to therapeutic applications. Angew. Chem. Int. Ed. Engl. 48, 1378-1398.
17. MCCARTY, D.M., MONAHAN, P.E., and SAMULSKI, R.J. (2001). Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis. Gene Ther. 8, 1248-1254.
18. MCINTYRE, G.J., and FANNING, G.C. (2006). Design and cloning strategies for constructing shRNA expression vectors. BMC Biotechnol. 6, 1.
19. MERL, S., MICHAELIS, C., JASCHKE, B., VORPAHL, M., SEIDL, S., and WESSELY, R. (2005). Targeting 2A protease by RNA interference attenuates coxsackieviral cytopathogenicity and promotes survival in highly susceptible mice. Circulation 111, 1583-1592.
20. MERL, S., and WESSELY, R. (2007). Anti-coxsackieviral efficacy of RNA interference is highly dependent on genomic target selection and emergence of escape mutants. Oligonucleotides 17, 44-53.
21. OBERSTE, M.S., MAHER, K., KENNETT, M.L., CAMPBELL, J.J., CARPENTER, M.S., SCHNURR, D., and PALLANSCH, M.A. (1999). Molecular epidemiology and genetic diversity of echovirus type 30 (E30): genotypes correlate with temporal dynamics of E30 isolation. J. Clin. Microbiol. 37, 3928-3933.
22. RACANIELLO, V.R. (2007). Picornaviridae: the viruses and their replication. In: Fields Virology, 5th edition. D.M. Knipe, and P.M. Howley, eds. (Lippincott Williams Wilkins, Philadelphia), pp. 795-838.
23. ROTHE, D., WERK, D., NIEDRIG, S., HORBELT, D., GRU-NERT, H.P., ZEICHHARDT, H., ERDMANN, V.A., and KURRECK, J. (2009). Antiviral activity of highly potent siR-NAs against echovirus 30 and its receptor. J. Virol. Methods 157, 211-218.
24. SAULNIER, A., PELLETIER, I., LABADIE, K., and COLBERE-GARAPIN, F. (2006). Complete cure of persistent virus infections by antiviral siRNAs. Mol. Ther. 13, 142-150.
25. SCHOPMAN, N.C., LIU, Y.P., KONSTANTINOVA, P., TER BRAKE, O., and BERKHOUT, B. (2010). Optimization of shRNA inhibitors by variation of the terminal loop sequence. Antiviral Res. 86, 204-211.
26. SCHUBERT, S., GRUNERT, H.P., ZEICHHARDT, H., WERK, D., ERDMANN, V.A., and KURRECK, J. (2005). Maintaining inhibition: siRNA double expression vectors against coxsack-ieviral RNAs. J. Mol. Biol. 346, 457-465.
27. SIOMI, H., and SIOMI, M.C. (2009). On the road to reading the RNA-interference code. Nature 457, 396-404.
28. SUZUKI, H., SAITOH, H., SUZUKI, T., and TAKAKU, H. (2009). Baculovirus-mediated bispecific short-hairpin small-interfering RNAs have remarkable ability to cope with both influenza viruses A and B. Oligonucleotides 19, 307-316.
29. TER BRAKE, O., KONSTANTINOVA, P., CEYLAN, M., and BERKHOUT, B. (2006). Silencing of HIV-1 with RNA interference: a multiple shRNA approach. Mol. Ther. 14, 883-892.
30. TER BRAKE, O., 'T HOOFT, K., LIU, Y.P., CENTLIVRE, M., VON EIJE, K.J., and BERKHOUT, B. (2008). Lentiviral vector design for multiple shRNA expression and durable HIV-1 inhibition. Mol. Ther. 16, 557-564.
31. VELDWIJK, M.R., TOPALY, J., LAUFS, S., HENGGE, U.R., WENZ, F., ZELLER, W.J., and FRUEHAUF, S. (2002). Development and optimization of a real-time quantitative PCR-based method for the titration of AAV-2 vector stocks. Mol. Ther. 6, 272-278.
32. WHITTON, J.L., CORNELL, C.T., and FEUER, R. (2005). Host and virus determinants of picornavirus pathogenesis and tropism. Nat. Rev. Microbiol. 3, 765-776.
33. WILSON, J.A., and RICHARDSON, C.D. (2005). Hepatitis C virus replicons escape RNA interference induced by a short interfering RNA directed against the NS5b coding region. J. Virol. 79, 7050-7058.
34. XU, X.M., YOO, M.H., CARLSON, B.A., GLADYSHEV, V.N., and HATFIELD, D.L. (2009). Simultaneous knockdown of the expression of two genes using multiple shRNAs and subsequent knock-in of their expression. Nat. Protoc. 4, 1338-1348.
35. ZOLOTUKHIN, S., BYRNE, B.J., MASON, E., ZOLOTUKHIN, I., POTTER, M., CHESNUT, K., SUMMERFORD, C., SA-MULSKI, R.J., and MUZYCZKA, N. (1999). Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. Gene Ther. 6, 973-985.